These findings imply that G-CSF contributes to glioblastoma progression and there blocking by using the anticancer bacteriocin peptide Nisin may dampen tumor progression and will have better therapeutic response as angiogenesis inhibitors. This evidence concerns the gene CSF3 and glioblastoma.